A major breakthrough in cancer investigation is occurring with the use of VHH fragments to reactivate mutated p53. This vital tumor inhibitor protein is frequently inactivated in several forms of tumors, leading https://bookmarkcitizen.com/story21929260/nanobodies-revive-tumor-suppressor-p53-new-potential-approach-for-cancer-treatment